CDSCO panel Approves Sanofi's Protocol Amendment Proposal for to study Fitusiran Dr. Divya Colin2 Jun 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved drug major...
Johnson & Johnson concludes acquisition of Shockwave Medical Ruchika Sharma2 Jun 2024 3:31 PM ISTNew Brunswick: Johnson & Johnson has announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson &...
Moderna gets USFDA nod for mRNA RSV vaccine Ruchika Sharma2 Jun 2024 1:30 PM ISTCambridge: Moderna, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory...
Sanofi concludes acquisition of Inhibrx Ruchika Sharma2 Jun 2024 11:00 AM ISTParis: Sanofi has announced the completion of its acquisition of Inhibrx, Inc. The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s...
PGIMER Chandigarh Gets CDSCO Panel Nod to Study Bedaquiline Dr. Divya Colin1 Jun 2024 6:00 PM ISTNew Delhi: Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh has got approval from the Subject Expert Committee (SEC)...
Sanofi-Regeneron Dupixent recommended for EU approval by CHMP to treat COPD patients Ruchika Sharma1 Jun 2024 3:33 PM ISTParis: Sanofi and Regeneron have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...
Johnson & Johnson Executive Vice President William N Hait to retire Ruchika Sharma1 Jun 2024 2:15 PM ISTNew Brunswick: Johnson & Johnson has announced that William N. (Bill) Hait, M.D., Ph.D., will retire from his position as Executive Vice...
USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural Mesothelioma Ruchika Sharma1 Jun 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Results of Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024 Ruchika Sharma1 Jun 2024 11:30 AM ISTMumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced that the primary results of the Nidlegy Phase III PIVOTAL...
USFDA requests additional data on Sanofi Dupixent for treating smoker's lung Ruchika Sharma31 May 2024 3:16 PM ISTParis: Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) requested additional efficacy analyses on the efficacy...
Bristol Myers Squibb Breyanzi gets USFDA nod for Relapsed or Refractory Mantle Cell Lymphoma Ruchika Sharma31 May 2024 2:15 PM ISTPrinceton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted approval for Breyanzi (lisocabtagene...
Dr Reddy's Labs, Sun Pharma recall products in American market over manufacturing issues Ruchika Sharma31 May 2024 12:11 PM ISTNew Delhi: Dr Reddy's Laboratories and Sun Pharma are recalling products in the American market following manufacturing concerns, as stated by...
